High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: Role of partial rib resection

European Journal of Radiology

Volumn 72, Issue 1, 2009, Pages 160-166

  Zhu, Hui ^a   Zhou, Kun ^a   Zhang, Lian ^a   Jin, Chengbin ^a   Peng, Song ^a   Yang, Wei ^a   Li, Kequan ^a   Su, Haibing ^a   Chen, Wenzhi ^a   Bai, Jin ^a,b   Wu, Feng ^a,b   Wang, Zhibiao ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b National Engineering Research Center of Ultrasound Medicine   (China)

Author keywords

Hepatocellular carcinoma; High intensity focused ultrasound; Partial rib resection

Indexed keywords

ADVERSE EVENTS; BLOOD SUPPLY; CHONGQING UNIVERSITY; CLASSIFICATION ,; CLINICAL APPLICATION; ETHICS COMMITTEE; HEPATOCELLULAR CARCINOMA; HIFU THERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; INVASIVE TREATMENT; MEAN DIAMETER; MEDICAL SCIENCE; PARTIAL RIB RESECTION; PROSPECTIVE STUDY; SURVIVAL RATE; TUMOUR ABLATION; TUMOURS; ULTRASONIC BEAMS; ULTRASOUND ENERGY;

ACOUSTIC WAVES; MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATIENT MONITORING; ULTRASONIC IMAGING; ULTRASONIC TESTING; ULTRASONICS;

TUMORS;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; FEMALE; FOLLOW UP; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LIVER CELL CARCINOMA; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIB RESECTION; TUMOR VOLUME; VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RIBS; TREATMENT OUTCOME;

EID: 70349777985     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.07.003     Document Type: Article

References (28)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular Carcinoma. Lancet 362 (2003) 1907-1917
2. Livraghi T., Makuuchi M., and Buscarini L. Diagnosis and treatment of hepatocellular carcinoma (1997), Greenwich Medical Media, London
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 9319 (2002) 1734-1739
4. Bruix J., Sala M., and Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 5 Suppl. 1 (2004) S179-S188
5. Lo C.-M., Ngan H., Tso W.-K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
6. Lynn J.G., Zwemer R.L., and Chick A.J. A new method for the generation and use of focused ultrasound in experiment biology. J Gen Physiol 26 (1942) 179-193
7. Fry W.J., Mosberg Jr. W.H., Barnard J.W., and Fry F.J. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 11 (1954) 471-478
8. Wu F., Wang Z.B., Chen W.Z., et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem 11 (2004) 149-154
9. Wu F., Wang Z.B., Chen W.Z., et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235 (2005) 659-667
10. Ikeda K., Kumada H., Saitoh S., Arase Y., and Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 68 (1991) 2150-2154
11. Murakami T., Ishimaru H., Sakamoto I., et al. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 30 July-August (4) (2007) 696-704
12. Chapelier A.R., Bacha E.A., de Montpreville V.T., et al. Radical resection of radiation-induced sarcoma of the chest wall: report of 15 cases. Ann Thorac Surg 63 (1997) 214-219
13. Sakuraba M., Sagara Y., and Komatsu H. Surgical treatment of tuberculous abscess in the chest wall. Ann Thorac Surg 79 (2005) 964-967
14. Sanders R.J., and Hammond S.L. Subclavian vein obstruction without thrombosis. J Vasc Surg 41 (2005) 285-290
15. Scott W.W., Scott P.P., and Trerotala S.O. Radiology of the thoracic skeleton (1990), BC Decker, Philadephia
16. McCormack P.M. Use of prosthetic materials in chest-wall reconstruction. Assets and liabilities. Surg Clin North Am 69 (1989) 965-976
17. Livraghi T., Lazzaroni S., Pellicano S., Ravasi S., Torzilli G., and Vettori C. Percutaneous ethanol injection of hepatic tumours: single-session therapy with general anesthesia. AJR Am J Roentgenol 161 (1993) 1065-1069
18. Veltri A., Moretto P., Doriguzzi A., Pagano E., Carrara G., and Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16 March (3) (2006) 661-669 [Epub 2005 October 14]
19. Hori T., Nagata K., Hasuike S., et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 38 (2003) 977-981
20. Wu F., Wang Z.B., Lu P., et al. Activated anti-tumour immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol 30 (2004) 1217-1222
21. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
22. Pelletier G., Ducreux M., Gay F., et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 29 (1998) 129-134
23. Takayasu K., Arii S., Ikai I., et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 (2006) 461-469
24. Liao G.S., Yu C.Y., Shih M.L., et al. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol 34 January (1) (2008) 61-66 [Epub 2007 April 16]
25. Hynynen K., and Sun J. Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion. IEEE Trans Ultrason Ferroelectr Freq Control 46 3 (1999) 752-755
26. Kopelman D., Inbar Y., Hanannel A., et al. Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone-muscle interface in a porcine model. Eur J Clin Invest 38 April (4) (2008) 268-275
27. Civale J., Clarke R., Rivens I., and ter Haar G. The use of a segmented transducer for rib sparing in HIFU treatments. Ultrasound Med Biol 32 November (11) (2006) 1753-1761
28. Liu H.L., Chang H., Chen W.S., Shih T.C., Hsiao J.K., and Lin W.L. Feasibility of transrib focused ultrasound thermal ablation for liver tumours using a spherically curved 2D array: a numerical study. Med Phys 34 September (9) (2007) 3436-3448